A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-α2B in patients with metastatic melanoma
Michael B. Atkins, Jared A. Gollob, Jeffrey A. Sosman, David F. McDermott, Linda Tutin, Patricia Sorokin, Robert A. Parker, James W. Mier
Fingerprint
Dive into the research topics of 'A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-α2B in patients with metastatic melanoma'. Together they form a unique fingerprint.